Page 3 of articles about vaccine in Press releases
Pharmgate: PRRSGard® vaccine receives 24-month dating
Modified-live PRRS vaccine with innovative chimeric construction from Pharmgate.
Boehringer Ingelheim and Henke-Sass, Wolf develop innovative needle free injection device for pigs
Pirbright, ECO Animal Health, The Vaccine Group to develop new PRRS vaccines
Pharmgate: PRRSGard® vaccine now available in U.S. market
Modified-live PRRS vaccine has innovative chimeric construction.
Ceva opens new reference for autogenous vaccine manufacture
Ceva builds on its preventative health strategy with the opening of a new European reference for the manufacture of autogenous vaccines.
Hipradermic® 3.0: It’s time to feel the comfort
Hipra has just launched its Hipradermic® 3.0 device, a new and improved version of Hipradermic®: an intradermal needle-free jet injector for the vaccination of pigs.
The Roslin Institute: Stem cell approach to aid vaccine development
Method of producing blood cells will provide platform to aid development of vaccines against deadly infections in pigs such as ASF and PRRS.
Boehringer Ingelheim’s classical swine fever live vaccine approved
Ingelvac® CSF MLV, the first classical swine fever live vaccine jointly developed by a multinational company and Chinese research institutes.
Pirbright ASF vaccine protects pigs from developing severe disease
100 percent of pigs immunised with the new vaccine survived a lethal dose of ASF virus.
Pirbright shows new Nipah vaccines create ‘impressive’ immune response
Two new potential vaccines against Nipah virus developed by the University of Parma generate a strong immune response in pigs, and could be the key to preventing this deadly, zoonotic disease.
Boehringer Ingelheim introduces DiaTEC purification technology for Ingelvac CircoFLEX®
Salmonella vaccine now available to UK and Irish pig producers
Pig producers in the UK and Ireland have a new means of defense in the fight against salmonella with the launch of a highly effective salmonella vaccine that has already been well-proven in Germany and Poland.
Pirbright grants licence for new Foot-and-Mouth disease vaccine
Prevtec Microbia to be Acquired by Elanco
Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries
Ceva will launch Salmoporc in Austria, Belgium, Czech Republic, Denmark, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Slovak Republic, United Kingdom through the remainder of 2019.